PPIL4

Peptidyl-prolyl cis-trans isomerase-like 4 · Q8WUA2 · PPIL4 on Sugi Atlas →

0 patent compounds predicted against PPIL4, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to PPIL4 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From Real World PHASE4UNKNOWN
A Phase III, Randomized, Study of Aspirin and Esomeprazole Chemoprevention in Barrett's Metaplasia PHASE3COMPLETED
A Multicenter Study of NAP (AL-108) in Schizophrenia PHASE2COMPLETED
Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors PHASE1COMPLETED
Safety and Pharmacology of SNX-5422 Plus Carboplatin and Paclitaxel in Subjects With Solid Tumors PHASE1COMPLETED
A Study on Psychopathological Progress of Early Schizophrenia-Like Disorder (SOPRES) nanUNKNOWN
Identification of Acute Intermittent Porphyria Modifying Genes nanRECRUITING
Quantification of GADD34 Expression in RA nanCOMPLETED
Clubfoot DNA Repository nanCOMPLETED
Pulmonary Hypertension, Hypoxia and Sickle Cell Disease nanCOMPLETED
Autophagy Bladder Cancer nanUNKNOWN
Registry and Natural History Study for Early Onset Hereditary Spastic Paraplegia nanRECRUITING
FKBP5 Methylation and Childhood Emotional Abuse in Complex Posttraumatic Stress Disorder: Investigating the Relationship and Its Predictive Role in Therapy Outcome nanCOMPLETED
Mitoferrin-1 Expression in Erythropoietic Protoporphyria (Porphyria Rare Disease Clinical Research Consortium (RDCRC)) nanCOMPLETED
Cerebellar Mutism Syndrome Study nanRECRUITING
Biomarkers in the Diagnosis and Prognosis of NAFLD nanRECRUITING
Sensorimotor Gating in Schizophrenia nanCOMPLETED
Molecular Mechanisms of Exercise Benefits to Insulin Resistant People nanCOMPLETED
Abnormal Expression Proteins, Mitochondrial DNA and miRNA of Irritable Bowel Syndrome nanUNKNOWN
Clinical Diagnosis of Acute Porphyria nanCOMPLETED
Biomarkers in Idiopathic Juvenile Arthritis nanUNKNOWN
Parkinson's Diseases Susceptibility Genes and Pesticides nanCOMPLETED
Longitudinal Study of the Porphyrias nanRECRUITING
Effect of Supplementing a Mixed Macronutrient Beverage With Graded Doses of Leucine on Myofibrillar Protein Synthesis nanCOMPLETED
LIPCAR, Cuproptosis, and Α-SMA in the Pathogenesis of AMI and Remodeling nanNOT_YET_RECRUITING
Regulation of Mucosal Healing in Inflammatory Bowel Disease nanRECRUITING
Neuralized1 and RGS14 Genes nanCOMPLETED
Implementation of Molecular Diagnostic Pathways nanUNKNOWN
Genetic and Phenotypic Characteristics of Mitral Valve Prolapse nanUNKNOWN
Expression of Fas Protein in Skin Biopsies of Participants With Scarring Alopecia nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a PPIL4 binder may also engage these)

ProteinNameSimilarity
Q9CXG3 1.000 Q9CXG3 →
Q2U256 0.999 Q2U256 →
Q6Q151 0.997 Q6Q151 →
Q9UUE4 0.997 Q9UUE4 →
Q5ARI5 0.995 Q5ARI5 →
G5EEW6 0.994 G5EEW6 →
P0CP89 0.994 P0CP89 →
Q4WAQ9 0.994 Q4WAQ9 →
P0CP88 0.994 P0CP88 →
P0C1I6 0.994 P0C1I6 →
O94290 0.990 O94290 →
Q9FZ92 0.990 Q9FZ92 →
Q95Q98 0.989 Q95Q98 →
P25615 0.989 P25615 →
Q871A4 0.989 Q871A4 →
Q5SVQ0 0.989 Q5SVQ0 →
KAT7 Histone acetyltransferase KAT7 0.989 landscape →
Q4IE79 0.989 Q4IE79 →
Q61T02 0.988 Q61T02 →
P0C1J2 0.988 P0C1J2 →
A7A0P8 0.988 A7A0P8 →
P0C1I9 0.988 P0C1I9 →
Q5RC67 0.988 Q5RC67 →
Q6C710 0.988 Q6C710 →
Q19546 0.988 Q19546 →
Q71A39 0.988 Q71A39 →
A3GEV2 0.987 A3GEV2 →
Q7S9B6 0.987 Q7S9B6 →
Q09637 0.987 Q09637 →
A8X8D0 0.987 A8X8D0 →